Clinical Trials

70 enrolled

Ovarian Neoplasms

NCT07469202 2026-03-13

CYTALUX Dose Extension Study

106 enrolled

GynecologicThoracic

Lung Neoplasms, Ovarian Neoplasms

NCT06952660 2026-03-12

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

100 enrolled

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT05334706 2026-02-23

RIFT-HPV

69 enrolled

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

25 enrolled

Endometrial Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

120 enrolled

Uterine Cervical Neoplasms

NCT07256912 2026-02-13

CervALONE

1,266 enrolled

Phase 4 Active not recruiting

Vaccine Effectiveness

NCT07015957 2026-01-12

Kupewa: Optimizing Implementation Strategies for Cervical Cancer Prevention

7,000 enrolled

Cervical Cancer Prevention

NCT04145518 2025-12-12

MCUP

Phase 4 Completed

183 enrolled

Phase 4 Active not recruiting

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

NCT05651282 2025-08-29

RESToRE

250 enrolled

Endometrial Neoplasms

NCT07075250 2025-07-20

RIFOC003

30 enrolled

Platinum-resistant Ovarian Cancer (PROC)

NCT06897527 2025-07-08

A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Recurrent or Advanced Endometrial Cancer (EC)

100 enrolled

Endometrial Neoplasms

NCT01932125 2025-06-26

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Phase 4 Completed

100 enrolled

Classical hematologyGynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

12 enrolled

Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT06972693 2025-05-15

PERSONA-Ovary

Phase 4 Active not recruiting

323 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05266898 2025-04-18

AGO-Gard

250 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Dysplasia, Papillomavirus Infections

NCT06887933 2025-03-21

A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer

67 enrolled

Ovarian Neoplasms

NCT03164980 2025-03-20

COMPASS

Phase 4 Terminated

89 enrolled 20 charts